Bio-Thera Solutions, Ltd. (SHA:688177)
China flag China · Delayed Price · Currency is CNY
16.24
-0.53 (-3.16%)
At close: Sep 11, 2026

Bio-Thera Solutions Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
335.41218.61289.8163.99165.94847.47
Trading Asset Securities
60.12-90.22331.03629.89602.83
Cash & Short-Term Investments
395.52218.61380.02495.01795.831,450
Cash Growth
21.66%-42.47%-23.23%-37.80%-45.13%17.03%
Accounts Receivable
195.81164.7108.26148.7289.75103.32
Other Receivables
2.382.994.232.091.963.67
Receivables
198.18167.68112.5150.891.72106.99
Inventory
372.05312.42253.1231.23161.990.1
Other Current Assets
169.7259.84142.34133.36112.81123.08
Total Current Assets
1,135958.56887.951,0101,1621,770
Property, Plant & Equipment
1,1301,0711,0661,014693.91579.43
Long-Term Investments
15.6415.5515.710-21.1
Other Intangible Assets
280.9218.44224.1230.38234.18239.47
Long-Term Deferred Charges
3.293.683.52.01--
Other Long-Term Assets
9.9320.568.0919.8689.397.31
Total Assets
2,5752,2872,2062,2872,1802,618

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
247.21198.69199.49171.4583.7712.73
Accrued Expenses
70.03118.8188.5369.5167.4190.91
Short-Term Debt
104.9280.0888.75105.40.0130.05
Current Portion of Long-Term Debt
306.39231.69169.450.21--
Current Portion of Leases
-0.06-3.183.492.38
Current Income Taxes Payable
5.74---0-
Current Unearned Revenue
951.04731.82545.33318.5374.08381.61
Other Current Liabilities
61.086.214.237.179.748.36
Total Current Liabilities
1,7461,3671,096725.42538.5526.04
Long-Term Debt
486.69374.21370.43323.843-
Long-Term Leases
----3.01-
Long-Term Unearned Revenue
22.5724.9231.2925.1327.974.23
Other Long-Term Liabilities
195.29144.81----
Total Liabilities
2,4511,9111,4971,074572.48530.27

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
414.08414.08414.08414.08414.08414.08
Additional Paid-In Capital
3,0543,0543,0543,0543,0543,054
Retained Earnings
-3,344-3,092-2,766-2,256-1,861-1,381
Comprehensive Income & Other
-0.26-0.145.6800.01-0.13
Shareholders' Equity
123.94376.03708.091,2131,6072,088
Total Liabilities & Equity
2,5752,2872,2062,2872,1802,618

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
898686.04628.58482.629.5132.43
Net Cash (Debt)
-502.48-467.43-248.5612.39786.331,418
Net Cash Growth
----98.42%-44.54%14.41%
Net Cash Per Share
-1.22-1.13-0.600.031.903.46
Filing Date Shares Outstanding
415.76414.08414.08414.08414.08414.08
Total Common Shares Outstanding
415.76414.08414.08414.08414.08414.08
Working Capital
-610.96-408.8-207.78284.98623.761,244
Book Value Per Share
0.300.911.712.933.885.04
Tangible Book Value
-156.96157.59483.99982.341,3731,848
Tangible Book Value Per Share
-0.380.381.172.373.324.46
Buildings
-667.49291.95291.16281.63220.84
Machinery
-913.06663.05608.15569.52507.47
Construction In Progress
-47.24580.96505.21155.8395.04